Results 101 to 110 of about 9,122 (206)

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

open access: yesClinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T   +3 more
doaj  

An in vitro model for thyroid autoimmunity [PDF]

open access: yes, 1987
AM McGregor   +12 more
core   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

open access: yesActa Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H.   +5 more
doaj   +1 more source

Update on the medical treatment of Graves’ ophthalmopathy

open access: yesInternational Journal of General Medicine, 2009
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj  

Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]

open access: yesFront Endocrinol (Lausanne)
Yeung A   +9 more
europepmc   +1 more source

Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]

open access: yesCureus
Bonny M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy